Back
Kymera Therapeutics Vs. Korro Bio Industry Stock Comparison
Buy
54
KYMR
Kymera Therapeutics
Last Price:
48.79
Seasonality Move:
25.63%
Sell
31
KRRO
Korro Bio
Last Price:
38.78
Seasonality Move:
45.98%
Buy
54
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $46.45. The Score for KYMR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Korro Bio (KRRO)
is a Sell
Is Korro Bio a Buy, Sell or Hold?
- The current Korro Bio [KRRO] share price is $36.59. The Score for KRRO is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- KRRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.45
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
KRRO Stock Price Chart
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.73 | Buy |
| Relative Strength Index (14 RSI): | 52.28 | Buy |
| Chaikin Money Flow: | -113869 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.73 - 48.29) | Sell |
| Bollinger Bands (100): | (33.25 - 45.35) | Buy |
KRRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.4 | Sell |
| Relative Strength Index (14 RSI): | 37.62 | Sell |
| Chaikin Money Flow: | -11414 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.46 - 47.1) | Sell |
| Bollinger Bands (100): | (38 - 52.28) | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.36 | Buy |
| 20-day SMA: | 47.07 | Sell |
| 50-day SMA: | 44.69 | Buy |
| 200-day SMA: | 36.37 | Buy |
| 8-day EMA: | 46.63 | Sell |
| 20-day EMA: | 46.22 | Buy |
| 50-day EMA: | 43.92 | Buy |
| 200-day EMA: | 36.72 | Buy |
KRRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.42 | Sell |
| 20-day SMA: | 43.37 | Sell |
| 50-day SMA: | 43.76 | Sell |
| 200-day SMA: | 51.28 | Sell |
| 8-day EMA: | 39.6 | Sell |
| 20-day EMA: | 41.5 | Sell |
| 50-day EMA: | 43.08 | Sell |
| 200-day EMA: | 47.51 | Sell |
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.53 per share.
Korro Bio Earnings Growth & KRRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.52 per share, a decrease next quarter of $0.26 per share, an increase this year of $3.47 per share, and a decrease next year of $0.34 per share.
Kymera Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Korro Bio Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||